Bringing What We Learned at the Virtual ERS Conference Into Practice

Listen to experts report on current publications, posters, and sessions from a recent pulmonology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

SSc-ILD: Progress in Diagnosis and Treatment

Launched: September 25, 2020

SSc-ILD: Anti-acid Therapy Treatment
 

Launched: September 25, 2020

Updates on Mono and Combination Therapy
 

Launched: September 25, 2020

Real-world Long-term Experience with Antifibrotic Treatment

Launched: September 25, 2020

PF-ILD: Prevalence, Genetics, and Mortality

Launched: September 25, 2020

New Prospects for Diagnosis and Prognosis

Launched: September 25, 2020

PF-ILD: Treatment Efficacy Based on PF-ILD Subtype and Concomitant Treatment with RA Medication

Launched: September 25, 2020

PF-ILD: Treatment Efficacy Based on Disease Severity and with Progressive Phenotype

Launched: September 25, 2020